Angiotensin-converting enzyme inhibitor prevents oxidative stress, inflammation, and fibrosis in carbon tetrachloride-treated rat liver

References

• Abu Dayyeh BK, Yang M, Dienstag JL, Chung RT. (2011). The effects of angiotensin blocking agents on the progression of liver fibrosis in the HALT-C Trial cohort. Dig Dis Sci 56:564–8
   PubMed Web of Science ®Google Scholar
• Ali SA, Faddah L, Abdel-Baky A, Bayoumi A. (2010). Protective effect of L-carnitine and coenzyme Q10 on CCl4-induced liver injury in rats. Sci Pharm 78:881–96
   PubMedGoogle Scholar
• Bataller R, Gabele E, Parsons CJ, et al. (2005). Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats. J Hepatol 41:1046–55
   Web of Science ®Google Scholar
• Bataller R, Schwabe RF, Choi YH, et al. (2003a). NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 112:1383–94
   PubMed Web of Science ®Google Scholar
• Bataller RN, Gãbele E, Schoonhoven R, et al. (2003b). Prolonged infusion of angiotensin II into normal rats induces stellate cell activation and proinflammatory events in liver. Am J Physiol Gastrointest Liver Physiol 285:G642–51
   PubMed Web of Science ®Google Scholar
• Bieghs V, Trautwein C. (2013). The innate immune response during liver inflammation and metabolic disease. Trends Immunol 34:446–52
   PubMed Web of Science ®Google Scholar
• Bradley PP, Priebat DA, Christensen RD, Rothstein G. (1982). Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78:206–9
   PubMed Web of Science ®Google Scholar
• Britton RS, Bacon BR. (1994). Role of free radicals in liver diseases and hepatic fibrosis. Hepatogastroenterology 41:343–8
   PubMed Web of Science ®Google Scholar
• Chance B, Maehly A. (1955). Assay of catalase and peroxidases. Methods Enzymol 11:764–75
   Web of Science ®Google Scholar
• Colmenero J, Bataller R, Sancho-Bru P, et al. (2009). Effects of losartan on hepatic expression of nonphagocytic NADPH oxidase and fibrogenic genes in patients with chronic hepatitis C. Am J Physiol Gastrointest Liver Physiol 297:G726–34
   PubMed Web of Science ®Google Scholar
• Cui X, Shimizu I, Lu G, et al. (2003). Inhibitory effect of a soluble transforming growth factor-α type II receptor on the activation of rat hepatic stellate cells in primary culture. J Hepatol 39:731–7
   PubMed Web of Science ®Google Scholar
• Douros A, Kauffmann W, Bronder E, et al. (2013). Ramipril-induced liver injury: case report and review of the literature. Am J Hypertens 26:1070–5
   PubMed Web of Science ®Google Scholar
• Du WD, Zhang YE, Zhai WR, Zhou XM. (1999). Dynamic changes of type I, III and IV collagen synthesis and distribution of collagen-producing cells in carbon tetrachloride-induced rat liver fibrosis. World J Gastroenterol 5:397–403
   PubMed Web of Science ®Google Scholar
• Ekor M, Odewabi AO, Kale OE, et al. (2011). Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats. Hum Exp Toxicol 30:1840–8
   PubMed Web of Science ®Google Scholar
• El-Khatib AS, Mansour MA. (2001). Prior treatment with captopril attenuates carbon tetrachloride-induced liver injury in mice. Res Commun Mol Pathol Pharmacol 110:3–16
   PubMed Web of Science ®Google Scholar
• Galli A, Svegliati-Baroni G, Ceni E, et al. (2005). Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. J Hepatol 41:1074–84
   Web of Science ®Google Scholar
• Ghiassi-Nejad Z, Friedman SL. (2008). Advances in antifibrotic therapy. Expert Rev Gastroenterol Hepatol 2:803–16
   PubMedGoogle Scholar
• Giannini EG, Testa R, Savarino V. (2005). Liver enzyme alteration: a guide for clinicians. CMAJ 172:367–79
   PubMed Web of Science ®Google Scholar
• Guillaud O, Gurram KC, Puglia M, et al. (2013). Angiotensin blockade does not affect fibrosis progression in recurrent hepatitis c after liver transplantation. Transplant Proc 45:2331–6
   PubMed Web of Science ®Google Scholar
• Hagley M, Hulisz D, Burns C. (1993). Hepatotoxicity associated with angiotensin-converting enzyme inhibitors. Ann Pharmacother 27:228–31
   PubMed Web of Science ®Google Scholar
• He SX, Luo JY, Wang YP, et al. (2006). Effects of extract from Ginkgo biloba on carbon tetrachloride-induced liver injury in rats. World J Gastroenterol 12:3924–8
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea V, Friedman SL. (2011). Pathogenesis of liver fibrosis. Annu Rev Pathol Mech 6:425–56
   PubMed Web of Science ®Google Scholar
• Hirose A, Ono M, Saibara T, et al. (2007). Angiotensin II type 1 receptor blocker inhibits fibrosis in rat nonalcoholic steatohepatitis. Hepatology 45:1375–81
   PubMed Web of Science ®Google Scholar
• Ishizaka N, Saito K, Noiri E, et al. (2005). Administration of ANG II induces iron deposition and upregulation of TGF-beta1 mRNA in the rat liver. Am J Physiol Regul Integr Comp Physiol 288:R1063–70
   PubMed Web of Science ®Google Scholar
• Izzo JJL, Weir MR. (2011). Angiotensin-converting enzyme inhibitors. J Clin Hypertens (Greenwich) 13:667–75
   PubMed Web of Science ®Google Scholar
• Jin CF, Li B, Lin SM, et al. (2013). Mechanism of the inhibitory effects of Eucommia ulmoides Oliv. cortex extracts (EUCE) in the CCl 4 -induced acute liver lipid accumulation in rats. Int J Endocrinol 2013:751854
   PubMed Web of Science ®Google Scholar
• Jollow D, Mitchell J, Zampaglione N, Gillette J. (1974). Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology 11:151–69
   PubMed Web of Science ®Google Scholar
• Jonsson JR, Clouston AD, Ando Y, et al. (2001). Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 121:148–55
   PubMed Web of Science ®Google Scholar
• Khan R. (2012). Protective effects of Sonchus asper (L.) Hill, (Asteraceae) against CCl(4-)induced oxidative stress in the thyroid tissue of rats. BMC Complement Altern Med 12:181
   PubMed Web of Science ®Google Scholar
• Kim M, Baik S, Park D, et al. (2008). Angiotensin receptor blockers are superior to angiotensin-converting enzyme inhibitors in the suppression of hepatic fibrosis in a bile duct-ligated rat model. J Gastroenterol 43:889–96
   PubMed Web of Science ®Google Scholar
• Makani H, Messerli FH, Romero J, et al. (2012). Meta-analysis of randomized trials of angioedema as an adverse event of renin-angiotensin system inhibitors. Am J Cardiol 110:383–91
   PubMed Web of Science ®Google Scholar
• Metwally MA, Zein CO, Zein NN. (2004). Clinical significance of hepatic iron deposition and serum iron values in patients with chronic hepatitis C infection. Am J Gastroenterol 99:286–91
   PubMed Web of Science ®Google Scholar
• Mohammed NA, Abd El-Aleem S, Appleton I, et al. (2003). Expression of nitric oxide synthase isoforms in human liver cirrhosis. J Pathol 200:647–55
   PubMed Web of Science ®Google Scholar
• Nabeshima Y, Tazuma S, Kanno K, et al. (2006). Anti-fibrogenic function of angiotensin II type 2 receptor in CCl4-induced liver fibrosis. Biochem Biophys Res Commun 346:658–64
   PubMed Web of Science ®Google Scholar
• Nelson JE, Wilson L, Brunt EM, et al. (2010). Relationship between the pattern of hepatic iron deposition and histological severity in nonalcoholic fatty liver disease. Hepatology 53:448–57
   PubMed Web of Science ®Google Scholar
• Niehaus WG, Samuelsson B. (1968). Formation of malonaldehyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 6:126–30
   PubMedGoogle Scholar
• Otogawa K, Kinoshita K, Fujii H, et al. (2007). Erythrophagocytosis by liver macrophages (kupffer cells) promotes oxidative stress, inflammation, and fibrosis in a rabbit model of steatohepatitis. Am J Pathol 170:967–80
   PubMed Web of Science ®Google Scholar
• Paizis G, Cooper ME, Schembri JM, et al. (2002). Up-regulation of components of the renin-angiotensin system in the bile duct-ligated rat liver. Gastroenterology 123:1667–76
   PubMed Web of Science ®Google Scholar
• Paizis G, Tikellis C, Cooper ME, et al. (2005). Chronic liver injury in rats and humans upregulates the novel enzyme angiotensin converting enzyme 2. Gut 54:1790–6
   PubMed Web of Science ®Google Scholar
• Purohit V, Russo D, Salin M. (2003). Role of iron in alcoholic liver disease: introduction and summary of the symposium. Alcohol 30:93–7
   PubMed Web of Science ®Google Scholar
• Ramaiah SK, Jaeschke H. (2007). Role of Neutrophils in the pathogenesis of acute inflammatory liver injury. Toxicol Pathol 35:757–66
   PubMed Web of Science ®Google Scholar
• Sebastiani G, Gkouvatsos K, Maffettone C, et al. (2011). Accelerated CCl4-induced liver fibrosis in Hjv-/- mice, associated with an oxidative burst and precocious profibrogenic gene expression. PLoS One 6:e25138
   PubMed Web of Science ®Google Scholar
• Tilg H, Moschen AR. (2010). Evolution of inflammation in nonalcoholic fatty liver disease: The multiple parallel hits hypothesis. Hepatology 52:1836–46
   PubMed Web of Science ®Google Scholar
• Tipoe G, Leung T, Liong E, et al. (2006). Inhibitors of inducible nitric oxide (NO) synthase are more effective than an no donor in reducing carbon tetrachloride-induced acute liver injury. Histol Histopathol 21:1157–65
   PubMed Web of Science ®Google Scholar
• Tiwari BK, Kumar D, Abidi AB, Rizvi SI. (2014). Efficacy of Composite extract from leaves and fruits of medicinal plants used in traditional diabetic therapy against oxidative stress in alloxan-induced diabetic rats. ISRN Pharmacol 2014:7
   Google Scholar
• Tomita K, Tamiya G, Ando S, et al. (2006). Tumour necrosis factor alpha signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice. Gut 55:415–24
   PubMed Web of Science ®Google Scholar
• Tracey WR, Tse J, Carter G. (1995). Lipopolysaccharide-induced changes in plasma nitrite and nitrate concentrations in rats and mice: pharmacological evaluation of nitric oxide synthase inhibitors. J Pharmacol Exp Ther 272:1011–15
   PubMed Web of Science ®Google Scholar
• Tung BY, Emond MJ, Bronner MP, et al. (2003). Hepatitis C, iron status, and disease severity: relationship with HFE mutations. J Gastroenterol 124:318–26
   Web of Science ®Google Scholar
• Turkay C, Yonem O, Arici S, et al. (2008). Effect of angiotensin-converting enzyme inhibition on experimental hepatic fibrogenesis. Dig Dis Sci 53:789–93
   PubMed Web of Science ®Google Scholar
• Ueki M, Koda M, Yamamoto S, et al. (2006). Preventive and therapeutic effects of angiotensin II type 1 receptor blocker on hepatic fibrosis induced by bile duct ligation in rats. J Gastroenterol 41:996–1004
   PubMed Web of Science ®Google Scholar
• von Montfort C, Matias N, Fernandez A, et al. (2012). Mitochondrial GSH determines the toxic or therapeutic potential of superoxide scavenging in steatohepatitis. J Hepatol 57:852–9
   PubMed Web of Science ®Google Scholar
• Wang HJ, Gao B, Zakhari S, Nagy LE. (2012). Inflammation in Alcoholic Liver Disease. Annu Rev Nutr 32:343–68
   PubMed Web of Science ®Google Scholar
• Weber LWD, Boll M, Stampfl A. (2003). Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit Rev Toxicol 33:105–36
   PubMed Web of Science ®Google Scholar
• Witko-Sarsat V, Friedlander M, Capeillère-Blandin C, et al. (1996). Advanced oxidation protein products as a novel marker of oxidative stress in uremia. Kidney Int 49:1304–13
   PubMed Web of Science ®Google Scholar
• Wu CH. (1999). Fibrodynamics-elucidation of the mechanisms and sites of liver fibrogenesis. World J Gastroenterol 5:388–90
   PubMed Web of Science ®Google Scholar
• Yang L, Bataller R, Dulyx J, et al. (2005). Attenuated hepatic inflammation and fibrosis in angiotensin type 1a receptor deficient mice. J Hepatol 43:317–23
   PubMed Web of Science ®Google Scholar
• Yang Q, Shi Y, He J, Chen Z. (2012). The evolving story of macrophages in acute liver failure. Immunol Lett 147:1–9
   PubMed Web of Science ®Google Scholar
• Yeung E, Wong FS, Wanless IR, et al. (2003). Ramipril-associated hepatotoxicity. Arch Pathol Lab Med 127:1493–7
   PubMed Web of Science ®Google Scholar
• Yi E-T, Liu R-X, Wen Y, Yin C-H. (2012). Telmisartan attenuates hepatic fibrosis in bile duct-ligated rats. Acta Pharmacol Sin 33:1518–24
   PubMed Web of Science ®Google Scholar
• Zhu W, Fung PC. (2000). The roles played by crucial free radicals like lipid free radicals, nitric oxide, and enzymes NOS and NADPH in CCl4-induced acute liver injury of mice. Free Radic Biol Med 29:870–80
   PubMed Web of Science ®Google Scholar